American Journal on Addictions

Papers
(The TQCC of American Journal on Addictions is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Brief Report: Increased Addictive Internet and Substance Use Behavior During the COVID‐19 Pandemic in China318
Internet Addiction Increases in the General Population During COVID‐19: Evidence From China96
Editorial: Challenges to Opioid Use Disorders During COVID‐1965
Microinduction of Buprenorphine/Naloxone: A Review of the Literature57
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone55
Increasing Heroin‐Methamphetamine (Goofball) Use and Related Morbidity Among Seattle Area People Who Inject Drugs39
Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID‐19 pandemic34
The Increasing Prevalence of Fentanyl: A Urinalysis‐Based Study Among Individuals With Opioid Use Disorder in New York City24
Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study21
Examining Associations Between Licensed and Unlicensed Outlet Density and Cannabis Outcomes From Preopening to Postopening of Recreational Cannabis Outlets21
Building Outreach and Diversity in the Field of Addictions21
Prevalence of problematic Internet use and its association with quality of life among undergraduate nursing students in the later stage of COVID‐19 pandemic era in China20
A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?18
Review Article: Anabolic‐Androgenic Steroids, Violence, and Crime: Two Cases and Literature Review18
Development and Feasibility Study of an Addiction‐Focused Phenotyping Assessment Battery18
Addiction Psychiatry and Addiction Medicine: The Evolution of Addiction Physician Specialists17
A Case Report: Rapid Micro‐Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended‐Release in an Adolescent With Severe Opioid Use Disorder17
Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings15
Substance use, depression, and loneliness among American veterans during the COVID‐19 pandemic15
Brief Report: The Impact of COVID‐19 on Emergency Department Overdose Diagnoses and County Overdose Deaths13
Cannabis use disorder and increased risk of arrhythmia‐related hospitalization in young adults13
Race, Ethnicity, and Clinical Features of Alcohol Use Disorder Among US Military Veterans: Results From the National Health and Resilience in Veterans Study12
Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient program12
Case Series: Cariprazine for treatment of methamphetamine use disorder11
Open‐label trial of a single‐day induction onto buprenorphine extended‐release injection for users of heroin and fentanyl10
Admissions to substance use treatment facilities for cannabis use disorder, 2000–2017: Does legalization matter?10
A Healthcare System‐Level Intervention to Increase Naloxone Availability for Patients With Opioid Prescriptions10
Buprenorphine Medication for Opioid Use Disorder: A Study of Factors Associated With Postpartum Treatment Retention9
Alexithymia, Emotion‐Regulation Strategies, and Traumatic Experiences in Prenatally Cocaine‐Exposed Young Adults9
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths9
Zonisamide as an Adjunctive Treatment to Cognitive Processing Therapy for Veterans With Posttraumatic Stress Disorder and Comorbid Alcohol Use Disorder: A Pilot Study8
Nitrous Oxide Inhalant Use Disorder Preceding Symptoms Concerning for Primary Psychotic Illness8
Single‐use, co‐use, and polysubstance use of alcohol, tobacco, and cannabis in sexual minority and heterosexual females7
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex7
Chronic Pain Among Patients With an Opioid Use Disorder7
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended‐Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens6
Associations Between Self‐Reported and Biological Measures of Nicotine Consumption Among Young Adult Nondaily Cigarette Smokers6
Food insecurity risk and alcohol use disorder in US young adults: Findings from the National Longitudinal Study of Adolescent to Adult Health6
Systematic review: Rates of psychopathology, substance misuse, and neuropsychological dysfunction among transitional age youth experiencing homelessness6
A Comparison of Mental and Behavioral Health Risks Factors Associated With Current Dual Use of Electronic Cigarette and Conventional Tobacco Cigarettes With Exclusive Tobacco Cigarette Use and Nonuse 6
β‐Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use6
Women's and men's experiences in group therapy for substance use disorders: A qualitative analysis6
Binge drinking and sexual risk behavior among US sexual and gender minority college students6
Systematic Review and Meta‐Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder6
Brief Report: Relationship Between Cotinine Levels and Peripheral Endogenous Concentrations of Oxytocin, β‐Endorphin, and Orexin in Individuals With Both Alcohol and Nicotine Use Disorders5
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience5
Cigarette, e‐cigarette, and dual use during the third trimester of pregnancy in a national sample of heterosexual and sexual minority women5
Clinical correlates of drug‐related dreams in opioid use disorder5
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment5
Congenital syphilis prevention in the context of methamphetamine use and homelessness5
Shifts in Unintentional Exposure to Drugs Among People Who Use Ecstasy in the Electronic Dance Music Scene, 2016‐20195
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial5
Prevalence, correlates, and consequences of attention‐deficit/hyperactivity disorder in a clinical sample of adults with tramadol use in Egypt5
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder5
5
Reduced alcohol use in patients prescribed pioglitazone5
Main and Interactive Effects of Nicotine Product Type on Sleep Health Among Dual Combustible and E‐Cigarette Users5
Cingulate Cortex Structural Alterations in Substance Use Disorder Psychiatric Inpatients4
Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study4
Systematic Review: Treatment for Addictive Disorder in Transplant Patients4
Correlates of optimism among patients in substance use disorder inpatient treatment4
Nicotine Inhalation and Suicide: Clinical Correlates and Behavioral Mechanisms4
CME Posters (n = 64)4
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders4
Characterizing autistic traits in treatment‐seeking young adults with substance use disorders4
Addiction, Race, and the Structurally Vulnerable4
Alcohol Craving and Psychiatric Disorders Among Current Drinkers4
A cross‐sectional study: Nitrous oxide abuse in Parisian medical students4
Commentary: It Is Not About Supply, It Is About Demand: Why the Self‐Medication Hypotheses Is Still So Important4
Factors associated with readmission to alcohol and opioid detoxification in the Alaska Interior4
A longitudinal study on the impact of Internet gaming disorder on self‐perceived health, academic performance, and social life of first‐year college students4
Systematic review: Wearable remote monitoring to detect nonalcohol/nonnicotine‐related substance use disorder symptoms4
Disentangling the Social Context of Nonmedical Use of Prescription Stimulants in College Students4
Legalization of cannabis in Canada—Local media analysis4
The Efficacy of Combined Electroacupuncture and Auricular Pressure on Sleep Quality in Patients Receiving Methadone Maintenance Treatment4
Sexual minority disparities in opioid and benzodiazepine misuse among adults with opioid use disorder3
Parental influences on tobacco use and likelihood of future use among sexual minority young adult men and women in the United States3
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O3
3
Alcohol use at the intersection of sexual orientation and gender identity in a representative sample of youth in Colorado3
Outcomes associated with once‐daily versus multiple‐daily dosing of buprenorphine/naloxone for opioid use disorder3
Faith leaders’ perceptions of needle exchange programs in the rural Illinois Delta Region: Religion as a social determinant of health3
A systematic review of virtual reality therapies for substance use disorders: Impact on secondary treatment outcomes3
Substance use disorders and treatment in Asian American and Pacific Islander women: A scoping review3
Gender differences among persons entering medication treatment for opioid use disorder in the community3
Excessive Spending in a “Free‐to‐Play” Smartphone Game3
Demographic, Behavioral, and Proximal Risk Factors for Gambling Disorder in the US Military3
Case Report: Buprenorphine—A Treatment for Psychological Pain and Suicidal Ideation?3
A pilot test of Written Exposure Therapy for PTSD in residential substance use treatment3
Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting2
Comprehensive analysis of discharge reasons from methadone outpatient treatment programs2
Prescription Drug Monitoring Program: Access in the First Year2
Substance use treatment services utilization and outcomes among probationers in drug courts compared to a matched cohort of probationers in traditional courts2
The association between adverse childhood experiences and treatment response for adults with alcohol and other drug use disorders2
Opioid use disorder at delivery hospitalization in the United States: 2012–20162
Poster Presentation Abstracts (CME and Non‐CME)2
Essential components of physician health program monitoring for substance use disorder: A survey of participants 5 years post successful program completion2
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study2
Trajectories of prescription opioid and heroin use in adulthood2
Illegal behaviors as a consequence of gambling disorder2
Association of Mood and Anxiety Disorders and Opioid Prescription Patterns Among Postpartum Women2
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students2
Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic2
Persistence of Operant Responding for Food After Prior Cocaine Exposure in Fischer 344 But Not Lewis Rats2
Trends in substance use disorder diagnoses among Veterans, 2009–20192
Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies2
Ketamine use in relation to depressive symptoms among high school seniors2
2
Hazardous Alcohol Use, Impulsivity, and HIV‐Risk Behavior Among HIV‐Positive Russian Patients With a History of Injection Drug Use2
Assessing the quality of publicly available videos on MDMA‐assisted psychotherapy for PTSD2
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis2
Age of gambling onset and resultant gambling behavior during young adulthood in the United States2
Comparing substance use treatment initiation and retention between telehealth delivered during COVID‐19 and in‐person treatment pre‐COVID‐192
Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder2
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort2
Brief Report: Expectancies for alcohol analgesia are associated with greater alcohol use among moderate‐to‐heavy drinkers without chronic pain2
Drugs and bugs: Negative affect, psychostimulant use and withdrawal, and the microbiome2
2
Examining Overdose and Homelessness as Predictors of Willingness to Use Supervised Injection Facilities by Services Provided Among Persons Who Inject Drugs2
Brief Report: Rates of Fentanyl Use Among Psychiatric Emergency Room Patients2
Risk of Relapse Among Opioid‐Dependent Patients Treated With Extended‐Release Naltrexone or Buprenorphine‐Naloxone: A Randomized Clinical Trial2
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics1
Medication treatment for alcohol use disorder in special populations1
Daily cannabis use may cause cannabis‐induced hyperalgesia1
Issue Information ‐ Editorial Board1
Social vulnerability predictors of drug poisoning mortality: A machine learning analysis in the United States1
Racial/ethnic discrimination, ADH1B*3, and coping‐motivated drinking among Black college students1
Call for special issue 20231
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic1
Sleep disturbance in clients attending a specialist addiction clinic1
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?1
Brief Report: Predictors of Relapse for Patients With Dextromethorphan Dependence1
Extended‐release buprenorphine in pregnancy1
Opioid Response Network1
Opioid use disorder in the active service: Implications for intervention1
Educating the community about the opioid epidemic and medications for opioid use disorder1
Factors associated with dual and polytobacco use among people in residential substance use disorder treatment1
Cognitive improvement among abstinent methamphetamine users: A 2‐year prospective longitudinal study1
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment1
Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit1
1
Methadone‐Assisted Opiate Withdrawal and Subsequent Heroin Abstinence: The Importance of Psychological Preparedness1
Tobacco/nicotine use among individuals using cannabis for therapeutic purposes1
AAAP PIPs 20221
1
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs1
Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross‐sectional study in Japan1
Symposia, Case Conference, Medical Update, and Case Summaries1
Predictors of protein intake among people who inject drugs in Los Angeles and San Francisco, California1
A call for increased addiction psychiatrist engagement in medical student education1
Barriers to recovery for medical professionals: Assessing financial support through a survey of Physician Health Programs1
PCSS Overview 20201
Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report1
Associations of cannabis use frequency and cannabis use disorder with receiving a substance use screen and healthcare professional discussion of substance use1
Advocacy and Public Policy Efforts of the American Academy of Addiction Psychiatry1
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression1
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users1
Averting neonatal abstinence syndrome and treating addiction among rural, opioid‐using young women1
1
The Development of Fellowship Training in Addiction Psychiatry1
Stand against stigma1
Systematic review and meta‐analysis: Combining transcranial magnetic stimulation or direct current stimulation with pharmacotherapy for treatment of substance use disorders1
Evaluation of a Novel Protocol for Assessment and Treatment of Alcohol Withdrawal Syndrome in Psychiatric Inpatients1
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting1
1
Conference Schedule1
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial1
0.055399179458618